Crossmark

Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-018-0135-3

Published Online: 2018-03-15

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Schmidt, Volker

Niederwieser, Dietger

Schenk, Thomas

Behre, Gerhard

Klink, Anne

Pfrepper, Christian

Hinke, Axel

Beelen, Dietrich W.

Junghanss, Christian

Uharek, Lutz

Krüger, William H.

Hochhaus, Andreas

Sayer, Herbert G.
License Information

Text and Data Mining valid from 2018-03-15
More Information

Article History

Received: 23 August 2017

Revised: 20 January 2018

Accepted: 6 February 2018

First Online: 15 March 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below